2-hydroxychavicol has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aneja, R; Asif, G; Gundala, SR; Lakshminarayana, N; Pandey, A; Paranjpe, R; Sagwal, A | 1 |
| Aneja, R; Brahmbhatt, M; Cheng, A; Gundala, SR; Mukkavilli, R; Pannu, V; Paranjpe, R; Reid, MD; Yang, C | 1 |
2 other study(ies) available for 2-hydroxychavicol and Cancer of Prostate
| Article | Year |
|---|---|
Piper betel leaf extract: anticancer benefits and bio-guided fractionation to identify active principles for prostate cancer management.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemical Fractionation; Chromatography, High Pressure Liquid; Eugenol; Humans; Immunohistochemistry; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Methanol; Mice; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Piper; Plant Extracts; Plant Leaves; Prostatic Neoplasms; Solvents; Xenograft Model Antitumor Assays | 2013 |
Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis.
Topics: Animals; Apoptosis; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Eugenol; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Piper betle; Plant Leaves; Prostatic Neoplasms; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2014 |